Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

MDxHealth (MDXH) Cost of Revenue: 2021-2025

Historic Cost of Revenue for MDxHealth (MDXH) over the last 5 years, with Sep 2025 value amounting to $9.6 million.

  • MDxHealth's Cost of Revenue rose 5.71% to $9.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $36.6 million, marking a year-over-year increase of 12.94%. This contributed to the annual value of $34.9 million for FY2024, which is 32.91% up from last year.
  • Per MDxHealth's latest filing, its Cost of Revenue stood at $9.6 million for Q3 2025, which was up 5.75% from $9.0 million recorded in Q2 2025.
  • MDxHealth's Cost of Revenue's 5-year high stood at $9.6 million during Q3 2025, with a 5-year trough of $3.3 million in Q1 2022.
  • Moreover, its 3-year median value for Cost of Revenue was $8.8 million (2025), whereas its average is $8.1 million.
  • In the last 5 years, MDxHealth's Cost of Revenue plummeted by 41.64% in 2022 and then skyrocketed by 83.42% in 2023.
  • MDxHealth's Cost of Revenue (MRQ) stood at $8.4 million in 2021, then tumbled by 32.93% to $5.7 million in 2022, then grew by 18.70% to $6.7 million in 2023, then soared by 37.09% to $9.2 million in 2024, then increased by 3.64% to $9.6 million in 2025.
  • Its last three reported values are $9.6 million in Q3 2025, $9.0 million for Q2 2025, and $8.8 million during Q1 2025.